FDA Inspection 1296202 — Daniel H. Chang, MD
The FDA completed an inspection of Daniel H. Chang, MD on Nov 7, 2025 in Bakersfield, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Bakersfield, CA (United States)
Additional details
Clinical Investigator (CI)